RAB Diagnostics Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 6

RAB Diagnostics General Information

Description

Developer of a drug development predictive tool designed for antibody-drug conjugates. The company develops advanced personalized cancer medicine with an innovative and proprietary biomarker platform, which is designed to predict patients' response to Antibody Drug Conjugates (ADCs) based on the detection of proteins, enabling pharmaceutical partners to improve patient selection, reduce risk in drug development, and enable effective precision oncology treatments.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ullernchausseen 64/66
  • 0379 Oslo
  • Norway
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • Ullernchausseen 64/66
  • 0379 Oslo
  • Norway

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RAB Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 18-Dec-2025 Completed Generating Revenue
3. Early Stage VC 01-Jan-2024 Completed Generating Revenue
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Jan-2023 Completed Startup
To view RAB Diagnostics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

RAB Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

RAB Diagnostics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aleap Accelerator/Incubator Minority
Angel (individual) Minority
Angel (individual) Minority
Startuplab Ventures Venture Capital Minority
Oslo University Hospital University
You’re viewing 5 of 6 investors. Get the full list »

RAB Diagnostics FAQs

  • When was RAB Diagnostics founded?

    RAB Diagnostics was founded in 2023.

  • Where is RAB Diagnostics headquartered?

    RAB Diagnostics is headquartered in Oslo, Norway.

  • What is the size of RAB Diagnostics?

    RAB Diagnostics has 9 total employees.

  • What industry is RAB Diagnostics in?

    RAB Diagnostics’s primary industry is Discovery Tools (Healthcare).

  • Is RAB Diagnostics a private or public company?

    RAB Diagnostics is a Private company.

  • What is RAB Diagnostics’s current revenue?

    The current revenue for RAB Diagnostics is .

  • Who are RAB Diagnostics’s investors?

    Aleap, , , Startuplab Ventures, and Oslo University Hospital are 5 of 6 investors who have invested in RAB Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process